Translational Genomics Research Institute-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2018

  1. Phase I study of CC-486 alone and in combination with carboplatin or nab-paclitaxel in patients with relapsed or refractory solid tumors

    Clinical Cancer Research, Vol. 24, Núm. 17, pp. 4072-4080